These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11050378)

  • 1. Low-molecular-weight heparin in patients with non-ST-segment elevation acute coronary syndrome: role in the emergency department.
    Goodman SG
    J Emerg Med; 2000 Oct; 19(3 Suppl):3S-11S. PubMed ID: 11050378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low molecular weight heparin in acute coronary syndrome: evidence for superior or equivalent efficacy compared with unfractionated heparin?
    Kaul S; Shah PK
    J Am Coll Cardiol; 2000 Jun; 35(7):1699-712. PubMed ID: 10841215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of low molecular weight heparins with antiplatelet agents in non-ST elevation acute coronary syndromes: an update.
    Cohen M
    Drugs; 2002; 62(12):1755-70. PubMed ID: 12149045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New advances in the management of acute coronary syndromes: 4. Low-molecular-weight heparins.
    Ageno W; Turpie AG
    CMAJ; 2002 Apr; 166(7):919-24. PubMed ID: 11949991
    [No Abstract]   [Full Text] [Related]  

  • 5. Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes.
    Magee KD; Sevcik W; Moher D; Rowe BH
    Cochrane Database Syst Rev; 2003; (1):CD002132. PubMed ID: 12535430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of low-molecular-weight heparins in the management of patients with unstable angina pectoris and non-Q-wave acute myocardial infarction.
    Monrad ES
    Am J Cardiol; 2000 Apr; 85(8A):2C-9C. PubMed ID: 10793174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of low-molecular-weight heparins in the management of unstable angina and non-ST-segment elevation myocardial infarction.
    Cohen M
    J Thromb Thrombolysis; 2001 Apr; 11(2):171-4. PubMed ID: 11406733
    [No Abstract]   [Full Text] [Related]  

  • 8. Antithrombotic therapy in unstable angina/non-ST elevation myocardial infarction: the evolving role of low-molecular-weight heparin.
    Antman EM; Kereiakes DJ
    J Invasive Cardiol; 2000 Dec; 12 Suppl E():E1-4;discussion E25-8. PubMed ID: 11156721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New anticoagulant options for ST-elevation myocardial infarction and unstable angina pectoris/non-ST-elevation myocardial infarction.
    Bates ER
    Curr Cardiol Rep; 2007 Jul; 9(4):289-97. PubMed ID: 17601395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of low-molecular-weight heparins in non-ST-segment elevation acute coronary syndromes.
    Nguyen-Ho P; Levine GN
    Panminerva Med; 2002 Jun; 44(2):115-22. PubMed ID: 12032429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-molecular-weight heparins in the treatment of acute coronary syndromes.
    Turpie AG; Antman EM
    Arch Intern Med; 2001 Jun; 161(12):1484-90. PubMed ID: 11427095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Low molecular weight heparin in the treatment of acute coronary syndromes without ST-segment elevation: unstable angina and non-Q-wave myocardial infarction].
    Borja J; Olivella P
    Med Clin (Barc); 2000 Nov; 115(15):583-6. PubMed ID: 11141394
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-molecular-weight heparin and platelet glycoprotein IIb/IIIa receptor blockade in the treatment of acute coronary syndromes: complementary or competing therapies?
    White HD
    J Invasive Cardiol; 2000 Feb; 12 Suppl A():6A-13A. PubMed ID: 10731290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New approaches to diagnosis and management of unstable angina and non-ST segment elevation myocardial infarction: controversial data.
    Borja J; Paz MA; Olivella P
    Arch Intern Med; 2002 Feb; 162(4):485-6. PubMed ID: 11863490
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of low-molecular-weight heparins in cardiovascular medicine.
    Hödl R; Klein W
    J Clin Pharm Ther; 2003 Oct; 28(5):371-8. PubMed ID: 14632961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical review of clinical trials for low-molecular-weight heparin therapy in unstable coronary artery disease.
    Husted S; Becker R; Kher A
    Clin Cardiol; 2001 Jul; 24(7):492-9. PubMed ID: 11444639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors.
    Lepor NE
    Rev Cardiovasc Med; 2007; 8 Suppl 3():S9-17. PubMed ID: 17917621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [2002 Update of the Guidelines of the Spanish Society of Cardiology for Unstable Angina/Without ST-Segment Elevation Myocardial Infarction].
    López Bescós L; Arós Borau F; Lidón Corbi RM; Cequier Fillat A; Bueno H; Alonso JJ; Coma Canella I; Loma-Osorio A; Bayón Fernández J; Masiá Martorell R; Tuñón Fernández J; Fernández-Ortiz A; Marrugat De La Iglesia J; Palencia Pérez M;
    Rev Esp Cardiol; 2002 Jun; 55(6):631-42. PubMed ID: 12113722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events.
    Cohen M; Demers C; Gurfinkel EP; Turpie AG; Fromell GJ; Goodman S; Langer A; Califf RM; Fox KA; Premmereur J; Bigonzi F
    Am J Cardiol; 1998 Sep; 82(5B):19L-24L. PubMed ID: 9737476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the use of unfractionated heparin in acute coronary syndrome outmoded?
    Chiquette E; Chilton R
    Curr Atheroscler Rep; 2004 Mar; 6(2):94-100. PubMed ID: 15023292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.